Jonathan R. Stretch

Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial

Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator

Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma

Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging

Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma

Histological regression in melanoma: impact on sentinel lymph node status and survival

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Molecular Genomic Profiling of Melanocytic Nevi

Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna

Current management of patients with melanoma who are found to be sentinel node‐positive

Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility

Whole-genome landscapes of major melanoma subtypes

Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center

Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

Improving Management and Patient Care in Lentigo Maligna by Mapping With In Vivo Confocal Microscopy

The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas

Margins of excision and prognostic factors for cutaneous eyelid melanomas

Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes

Surgeons’ Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey